2,019
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia

, MD PhD, , PhD, , MD PhD, , PhD & , PharmD BCCP

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Aastha Vats, Athira R Nair, Atithi K Bandhu, Divya Koirala, Manoj R Pallapothu, Maria G Quintana Mariñez, Mohana Chakkera, Niriksha Ravi, Rajita Ramaraju & Ana Francini. (2023) Treatment of Patients With Schizophrenia and Comorbid Chronic Hepatitis With Paliperidone: A Systematic Review. Cureus.
Crossref
Massimo Carlo Mauri, Gemma Franco, Alessandro Minutillo, Silvia Paletta, Chiara Di Pace, Alessandra Reggiori, Sara Baldelli & Dario Cattaneo. (2022) The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly. Journal of Clinical Psychopharmacology 42:1, pages 23-30.
Crossref
EHJ Krekels, AM Novakovic, AM Vermeulen, LE Friberg & MO Karlsson. (2017) Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia. CPT: Pharmacometrics & Systems Pharmacology 6:8, pages 543-551.
Crossref
A. Carlo Altamura, Giuseppe Delvecchio, Silvia Paletta, Chiara Di Pace, Alessandra Reggiori, Alessio Fiorentini, M. Donatella Mirabile, Riccardo A. Paoli, Claudia Cinnante, Fabio Triulzi, Massimo C. Mauri & Paolo Brambilla. (2017) Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study. Psychiatry Research: Neuroimaging 261, pages 80-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.